Drug MonographTirzepatide · GLP-1·GIP
Rx-only · Evidence-reviewed
Monograph · INN: tirzepatide
An evidence-based, drug-focused guide to tirzepatide. Tirzepatide Report reads the registration trials and the FDA label so every statement on this page is anchored to primary evidence — mechanism, dosing, safety, and how it compares.
Mechanism of action
At a glance. Compounded tirzepatide is not the FDA-approved branded product. This site is informational and not medical advice.
Where to get it · Doctor-reviewed
Tirzepatide is prescription-only. These are the telehealth programs we rank highest on price transparency, clinical oversight, and support. Some of them are affiliate partners, which we disclose so you can weigh the ranking with that in view.
Doctor-reviewed tirzepatide with one flat price and built-in human support.
$149/mo flat
Compounded tirzepatide (503A)
Prices tirzepatide openly and bills it a quarter at a time — $897 up front, with no monthly option behind it.
$299/mo avg (12-wk block)
compounded
Broad compounded storefront whose sublingual tirzepatide drops ($199/mo) undercut its own injection ($349/mo) — an inversion of the usual market rule.
$349/mo injection ($199 drops)
Compounded tirzepatide (injection and sublingual drops)
Asking something narrower? Compare every program by price, cheapest first, see who sells compounded tirzepatide and who names the pharmacy, or read what brand Zepbound costs. All of them are indexed on our rankings page.
Price index · computed from our provider dataset
Updated August 2026
Across the tracked programs publishing a confirmable price ($109–$429).
CoreAge Rx — one all-in price, no dose surcharge.
Advertising disclosure. Tirzepatide Report may earn a commission when you start treatment through these links, at no extra cost to you. See our disclosure.
Contents
An evidence-based guide to tirzepatide: how the dual GIP/GLP-1 drug works, what the trials show, the dosing ladder, side effects, and the ongoing-use reality.
ReadHow tirzepatide and semaglutide compare in the trials that put them head-to-head — SURPASS-2 for glucose, SURMOUNT-5 for weight loss. The honest verdict.
ReadThe tirzepatide titration schedule from the FDA label, why the dose climbs slowly, the common GI side effects, and practical ways to manage tolerability.
ReadWhat the SURMOUNT-4 trial shows about weight regain after stopping tirzepatide, and why it is an ongoing therapy rather than a short course.
ReadEvery Zepbound (tirzepatide) side effect from the FDA label, ranked by frequency — plus the gallbladder, pancreatitis, and thyroid warnings explained.
ReadIn Dec 2024 the FDA approved Zepbound for moderate-to-severe OSA in adults with obesity. What SURMOUNT-OSA showed, and why it's an adjunct, not a CPAP cure.
ReadA label-sourced walkthrough of injecting Zepbound (tirzepatide) — the pen, the vial, where to inject, site rotation, timing, storage, and sharps disposal.
ReadRetatrutide's Phase 2 weight-loss numbers beat tirzepatide's — but it is still investigational and not FDA-approved. An honest, evidence-based comparison.
ReadEvidence standard
Every claim traces to a registration trial, peer-reviewed paper, or the official FDA label.
Statements carry numbered references — including null results, caveats, and label warnings.
Some of the programs we rank are affiliate partners and pay us a commission. We say so on every page it applies to.
How we review and rank is set out in our editorial policy, and our independence is documented on the about page.